Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2002 2
2003 1
2004 3
2005 2
2006 6
2007 4
2008 2
2009 1
2010 2
2011 8
2012 7
2013 6
2014 6
2015 12
2016 5
2017 7
2018 7
2019 2
2020 2
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

82 results
Results by year
Filters applied: . Clear all
Page 1
Prognostic impact of GPR56 in patients with colorectal cancer.
Lim DR, Kang DH, Kuk JC, Kim TH, Shin EJ, Ahn TS, Kim HJ, Jeong DJ, Baek MJ, Kim NK. Lim DR, et al. Among authors: ahn ts. Neoplasma. 2021 May;68(3):580-589. doi: 10.4149/neo_2021_201209N1333. Epub 2021 Feb 24. Neoplasma. 2021. PMID: 33618521
Epigenetic inactivation of RUNX3 in colorectal cancer.
Shin EJ, Kim HJ, Son MW, Ahn TS, Lee HY, Lim DR, Bae SB, Jeon S, Kim H, Jeong D, Lee MS, Kim DS, Noh JS, Baek MJ. Shin EJ, et al. Among authors: ahn ts. Ann Surg Treat Res. 2018 Jan;94(1):19-25. doi: 10.4174/astr.2018.94.1.19. Epub 2017 Dec 28. Ann Surg Treat Res. 2018. PMID: 29333422 Free PMC article.
Defensin alpha 6 (DEFA6) is a prognostic marker in colorectal cancer.
Jeong D, Kim H, Kim D, Ban S, Oh S, Ji S, Kang D, Lee H, Ahn TS, Kim HJ, Bae SB, Lee MS, Kim CJ, Kwon HY, Baek MJ. Jeong D, et al. Among authors: ahn ts. Cancer Biomark. 2019;24(4):485-495. doi: 10.3233/CBM-182221. Cancer Biomark. 2019. PMID: 30932884
82 results